Jointly established by PolyU and The University of Hong Kong in November 2015, the Respiratory Virus Research Foundation is to lead respiratory viral infection research and their corresponding translational research in Hong Kong. With the support of various donors, the teams from the two universities will collaborate actively with the industry to develop technologies and translate the results into clinically applicable products - products that will help the clinical management of patients with acute respiratory viral infections; from diagnostics, vaccines, vaccine adjuvants, to treatment. It is hoped that this collaboration will help to provide greater protection to the community in Hong Kong and beyond.
 |
 |
